Indiana University School Of Medicine
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1903-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.medicine.iu.edu
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
- Conditions
- Germ Cell Tumor
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 37
- Registration Number
- NCT00198172
- Locations
- ๐บ๐ธ
Indiana University Cancer Center, Indianapolis, Indiana, United States
Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00198237
- Locations
- ๐บ๐ธ
Indiana University Cancer Center, Indianapolis, Indiana, United States
A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR
- Conditions
- Refractory Germ Cell Tumors Expressing EGRF
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-09-19
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT00198159
- Locations
- ๐บ๐ธ
Indiana University Cancer Center, Indianapolis, Indiana, United States
Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)
- Conditions
- Pancreas Neoplasms
- Interventions
- Drug: COX-2 Inhibitor 6-8 weeks prior to surgeryDrug: COX-2 Inhibitor for 6 months prior to follow-up EUS or ERCP
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-02-29
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 8
- Registration Number
- NCT00198081
- Locations
- ๐บ๐ธ
Indiana University Hospital, Indianapolis, Indiana, United States
Venlafaxine for Hot Flashes After Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2008-11-14
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 75
- Registration Number
- NCT00198250
- Locations
- ๐บ๐ธ
Indiana University Cancer Center, Indianapolis, Indiana, United States
Aripiprazole Treatment of Bipolar Depression
- Conditions
- Bipolar Depression
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-04-05
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT00198198
- Locations
- ๐บ๐ธ
UH 3124 University Hospital, Indianapolis, Indiana, United States
Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients
- Conditions
- Renal Failure
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2005-09-20
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT00198224
- Locations
- ๐บ๐ธ
University Hospital, Indianapolis, Indiana, United States
๐บ๐ธIndiana University Hospital and Emerson Hall, Indiana University School of Medicine, Indianapolis, Indiana, United States
A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients
- Conditions
- Panic Disorder
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-10-22
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 150
- Registration Number
- NCT00198094
- Locations
- ๐บ๐ธ
University of Pennsylvania, Mood and Anxiety Disorders Section, Philadelphia, Pennsylvania, United States
๐บ๐ธUniversity of South Florida, Department of Psychiatry and Behavioral Medicine, Tampa, Florida, United States
๐บ๐ธUniversity Hospital Outpatient Center, Psychiatry, Indianapolis, Indiana, United States
Prevention of Diabetes Progression Trial (PDPT)
- Conditions
- Newly Diagnosed With Type 1 Diabetes
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00198146
- Locations
- ๐บ๐ธ
Indiana University - Riley Hospital for Children, Indianapolis, Indiana, United States
Bisphosphonate Therapy for Osteogenesis Imperfecta
- Conditions
- Osteogenesis ImperfectaOsteoporosisPaget Disease of Bone
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00159419